Terumo Blood and Cell Technologies' Reveos(R) Automated Whole Blood Processing System cleared by FDA for US commercial use
Terumo Blood and Cell Technologies (Terumo BCT) announces US Food and Drug Administration (FDA) clearance of the Reveos Automated Whole Blood Processing System, the first whole blood automation device available in the US that processes whole blood into platelets and other components in a single centrifugation cycle ...
Source: pharmiweb.com